Jamieson Wellness Inc. Announces Voting Results from 2024 Annual Meeting of Shareholders
23 mai 2024 19h21 HE
|
Jamieson Wellness Inc.
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that each of the nominee directors listed in the management...
AXTI Stockholders: Robbins LLP Reminds AXTI Stockholders of Securities Fraud Class Action Against AXT, Inc.
23 mai 2024 18h37 HE
|
Robbins LLP
Robbins LLP is Investigating the Allegations that AXT, Inc. (AXTI) Misled Investors Regarding its Business Operations
BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
23 mai 2024 18h25 HE
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
ROSEN, A TOP RANKED LAW FIRM, Encourages Autodesk, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADSK
23 mai 2024 18h07 HE
|
The Rosen Law Firm PA
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Autodesk, Inc. (NASDAQ: ADSK) between June 1, 2023 and...
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AKRO
23 mai 2024 18h02 HE
|
The Rosen Law Firm PA
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Akero Therapeutics, Inc. (NASDAQ: AKRO) between September...
Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting
23 mai 2024 18h00 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven studies...
ROSEN, A TOP RANKED LAW FIRM, Encourages AST SpaceMobile, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ASTS
23 mai 2024 17h59 HE
|
The Rosen Law Firm PA
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AST SpaceMobile, Inc. (NASDAQ: ASTS) between November 14,...
Le conseil d’administration de Gildan démissionne
23 mai 2024 17h55 HE
|
Les Vêtements de Sport Gildan Inc.
• Vince Tyra a quitté ses fonctions de président et chef de la direction• Fin du processus de vente MONTRÉAL, 23 mai 2024 (GLOBE NEWSWIRE) -- Les Vêtements de Sport Gildan Inc. (GIL : TSX et...
Gildan Board of Directors Resigns
23 mai 2024 17h55 HE
|
Gildan Activewear, Inc.
Vince Tyra has Stepped Down as President and CEOSale Process has Ceased MONTREAL, May 23, 2024 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or “the Company”) today...
Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
23 mai 2024 17h51 HE
|
Coherus BioSciences, Inc.
CHS-114 shown to have an acceptable safety profile with no dose-limiting toxicities (DLTs) in heavily pretreated patients with solid tumors Selective depletion of peripheral CCR8+ regulatory T...